Prognostic significance of PAK family kinases in acute myeloid leukemia

Liang Quan, Zhiheng Cheng, Yifeng Dai, Yang Jiao, Jinlong Shi, Lin Fu*

*Corresponding author voor dit werk

    OnderzoeksoutputAcademicpeer review

    14 Citaten (Scopus)
    83 Downloads (Pure)


    Acute myeloid leukemia (AML) is a clonal and heterogeneous disease characterized by a myriad of genetic defects. Genetic abnormalities are powerful prognostic factors. P21-activated kinases (PAKs) are a kind of serine/threonine protein kinases, which is regulator of plenty of oncogenic signaling pathways. The clinical and prognostic value of PAKs in AML is unclear. A total of 155 AML patients with PAK expression data from The Cancer Genome Atlas database were enrolled in this study. Eighty-four patients underwent chemotherapy only, 71 also underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). In the chemotherapy-only group, high PAK3 and PAK7 expression were both bound up with poor EFS and OS (all P <0.05). However, high PAK2 expressers had better EFS and OS (all P <0.05). Multivariate analysis demonstrated that high PAK7 expression was an adverse independent prognostic factor in patients who received chemotherapy only. PAKs have no influence in EFS and OS in patients who underwent allo-HSCT. In conclusion, high PAK2 expression is a favorable prognostic factor, as to the high expression of PAK3 and PAK7, they are poor prognostic factors, and PAK7 has better prognostic value, but their prognostic effects can be offset by allo-HSCT.

    Originele taal-2English
    Pagina's (van-tot)30-37
    Aantal pagina's8
    TijdschriftCancer Gene Therapy
    Nummer van het tijdschrift1-2
    StatusPublished - feb.-2020


    Duik in de onderzoeksthema's van 'Prognostic significance of PAK family kinases in acute myeloid leukemia'. Samen vormen ze een unieke vingerafdruk.

    Citeer dit